A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC
Clinical trial NCT07062328 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07062328
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-10
- Primary completion
- 2026-12-10
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.